ABBV vs NFLX: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Netflix, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Netflix, Inc. · Communication Services
$73.68
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
NFLX has more upside to fair value
(+45.0%).
NFLX trades at a lower forward P/E
(23.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
NFLX |
| Current Price |
$261.07 |
$73.68 |
| Fair Value Estimate |
$264.30 |
$106.84 |
| Upside to Fair Value |
+1.2%
|
+45.0%
|
| Market Cap |
$461.3B |
$310.2B |
| Forward P/E |
128.0x
|
23.3x
|
| EV / EBITDA |
31.0x
|
9.2x
|
| Price / Sales |
7.3x
|
6.6x
|
| Price / FCF |
22.1x
|
26.1x
|
| Revenue Growth YoY |
+12.4%
|
+16.2%
|
| Gross Margin |
70.7%
|
49.0%
|
| Operating Margin |
27.6%
|
29.7%
|
| Return on Equity |
68.0%
|
49.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
3.83%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Netflix, Inc. operates as a leading global streaming entertainment service, delivering a wide variety of TV series, documentaries, and feature films across multiple genres and languages. The company exhibits high business quality with a durable competitive moat supported by strong brand recognition, intangible assets, and network effects. Its recent financial performance shows robust earnings gro…
Accumulation Zones
| Metric |
ABBV |
NFLX |
| Zone Low |
$198.23 |
$80.13 |
| Zone High |
$224.66 |
$90.81 |
| In Buy Zone? |
No
|
Yes
|